Mouse Model of Alzheimer’s Disease,” Neuroimage 55, no. 1 (March 1, 2011): 32–38.

225

C. C. Meltzer et al., “Serotonin in Aging, Late-Life Depression, and Alzheimer’s Disease: The Emerging Role of Functional Imaging,” Neuropsychopharmacology 18, no. 6 (June 1998): 407-30.

226

S. E. Hemby et al., “Neuron-Specific Age-Related Decreases in Dopamine Receptor Subtype mRNAs,” Journal of Comparative Neurology 456, no. 2 (February 3, 2003): 176-83. Jean-Claude Dreher et al., “Age-Related Changes in Midbrain Dopaminergic Regulation of the Human Reward System,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 39 (September 30, 2008): 15,106-11.

227

Thomas McNeill and Michael Jakowec, “Neurotransmitters: GABA and Glutamate,” Medicine Encyclopedia (2019), http://medicine.jrank.org/pages/1225/Neurotransmitters-GABA-glutamate.html.

228

J. L. Muir, “Acetylcholine, Aging, and Alzheimer’s Disease,” Pharmacology, Biochemistry, and Behavior 56, no. 4 (April 1997): 687-96.

229

John Hiscock, “Judi Dench Interview: ‘Retirement Is a Rude Word,’” Telegraph, February 21, 2015, https://www.telegraph.co.uk/culture/film/film-news/11420407/Judi-Dench-interview-second-exotic-marigold-hotel.html.

230

S. Samman et al., “Green Tea or Rosemary Extract Added to Foods Reduces Nonheme-Iron Absorption,” American Journal of Clinical Nutrition 73, no. 3 (March 2001): 607-12.

231

Y. Jiao et al., “Iron Chelation in the Biological Activity of Curcumin,” Free Radical Biology and Medicine 40, no. 7 (April 1, 2006): 1152-60.

232

Sonja Hilbrand et al., “Caregiving within and beyond the Family Is Associated with Lower Mortality for the Caregiver: A Prospective Study,” Evolution and Human Behavior 38, no. 3 (May 2017): 397–403.

233

M. C. Carlson et al., “Impact of the Baltimore Experience Corps Trial on Cortical and Hippocampal Volumes,” Alzheimer’s and Dementia 11, no. 11 (November 2015): 1340-48.

234

O. Dean et al., “N-acetylcysteine in Psychiatry: Current Therapeutic Evidence and Potential Mechanisms of Action,” Journal of Psychiatry and Neuroscience 36, no. 2 (March 2011): 78–86.

235

Там же.

236

J. C. Adair et al., “Controlled Trial of N-acetylcysteine for Patients with Probable Alzheimer’s Disease,” Neurology 57, no. 8 (October 23, 2001): 1515-17. W. R. Shankle et al., “CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer’s Disease and Cerebrovascular Disease,” Journal of Alzheimer’s Disease 54, no. 3 (October 4, 2016): 1073-84.

237

Wei Zheng et al., “Huperzine A for Treatment of Cognitive Impairment in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials,” Shanghai Archives of Psychiatry 28, no. 2 (April 25, 2016): 64–71.

238

Wei Zheng et al., “Adjunctive Huperzine A for Cognitive Deficits in Schizophrenia: A Systematic Review and Meta-Analysis,” Human Psychopharmacology 31, no. 4 (July 2016): 286-95.

239

B. S. Wang et al., “Efficacy and Safety of Natural Acetylcholinesterase Inhibitor Huperzine A in the Treatment of Alzheimer’s Disease: An Updated Meta-Analysis,” Journal of Neural Transmission 116, no. 4 (April 2009): 457-65.

240

M. A. Papandreou et al., “Inhibitory Activity on Amyloid-Beta Aggregation and Antioxidant Properties of Crocus sativus Stigmas Extract and Its Crocin Constituents,” Journal of Agricultural and Food Chemistry 54, no. 23 (November 15, 2006): 8762-68.

241

Shinji Soeda et al., “Neuroprotective Activities of Saffron and Crocin” в The Benefits of Natural Products for Neurogenerative Diseases: Advances in Neurobiology, vol. 12, eds. M. Mohamed Essa, Akbar Mohammed, and Gilles Guillemin (New York: Springer, 2016), 275-92.

242

M. Tsolaki et al., “Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial,” Journal of Alzheimer’s Disease 54, no. 1 (July 2016): 129-33. S. Akhondzadeh et al., “A 22-Week, Multicenter, Randomized, Double-Blind Controlled Trial of Crocus sativus in the Treatment of Mild-to-Moderate Alzheimer’s Disease,” Psychopharmacology 207, no. 4 (January 2010): 637-43. S. Akhondzadeh et al., “Saffron in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease: A 16-Week, Randomized and Placebo-Controlled Trial,” Journal of Clinical Pharmacy and Therapeutics 35, no. 5 (October 2010): 581-88. M. Farokhnia et al., “Comparing the Efficacy and Safety of Crocus sativus L. with Memantine in Patients with Moderate to Severe Alzheimer’s Disease: A Double-Blind Randomized Clinical Trial,” Human Psychopharmacology 29, no. 4 (July 2014): 351-59.

243

E. Tamaddonfard et al., “Crocin Improved Learning and Memory Impairments in Streptozotocin-Induced Diabetic Rats,” Iranian Journal of Basic Medical Sciences 16, no. 1 (January 2013): 91-100.

244

G. D. Geromichalos et al., “Saffron as a Source of Novel Acetylcholinesterase Inhibitors: Molecular Docking and In Vitro Enzymatic Studies,” Journal of Agricultural and Food Chemistry 60, no. 24 (June 2012): 6131-38.

245

Sabrina Morelli et al., “Neuronal Membrane Bioreactor as a Tool for Testing Crocin Neuroprotective Effect in Alzheimer’s Disease,” Chemical Engineering Journal 305 (December 2016): 69–78. M. Rashedinia et al., “Protective Effect of Crocin on Crolein-Induced Tau Phosphorylation in the Rat Brain,” Acta Neurobiologiae Experimentalis 75, no. 2 (2015): 208-19.

246

N. T. Tildesley et al., “Salvia lavandulaefolia (Spanish Sage) Enhances Memory in Healthy Young Volunteers,” Pharmacology Biochemistry and Behavior 75, no. 3 (June 2003): 669-74. A. B. Scholey et al., “An Extract of Salvia (Sage) with Anticholinesterase Properties Improves Memory and Attention in Healthy Older Volunteers,” Psychopharmacology 198, no. 1 (May 2008): 127-39. D. O. Kennedy et al., “Monoterpenoid Extract of Sage (Salvia lavandulaefolia) with Cholinesterase Inhibiting Properties Improves Cognitive Performance and Mood in Healthy Adults,” Journal of Psychopharmacology 25, no. 8 (August 2011): 1088-100.

247

Mohsen Hamidpour et al., “Chemistry, Pharmacology, and Medicinal Property of Sage (Salvia) to Prevent and